[1. Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004; 9:453-9.10.1111/j.1083-4389.2004.00260.x15361085]Open DOISearch in Google Scholar
[2. Zheng PY, Hua J, Yeoh KG, Ho B. Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population. Gut. 2000; 47:18-22.10.1136/gut.47.1.18172797710861258]Open DOISearch in Google Scholar
[3. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996; 20:1161-81.10.1097/00000478-199610000-000018827022]Open DOISearch in Google Scholar
[4. McGee DJ, Mobley HL. Pathogenesis of Helicobacter pylori infection. Curr Opin Gastroenterol. 2000; 16: 24-31.10.1097/00001574-200001000-0000517024012]Open DOISearch in Google Scholar
[5. Basso D, Navaglia F, Brigato L, Di Mario F, Rugge M, Plebani M. Helicobacter pylori non-cytotoxic genotype enhances mucosal gastrin and mast cell tryptase. J Clin Pathol. 1999; 52:210-4.10.1136/jcp.52.3.21050108110450181]Open DOISearch in Google Scholar
[6. Munoz S, Hernandez-Pando R, Abraham SN, Enciso JA. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol. 2003; 70:5590-6.10.4049/jimmunol.170.11.559012759438]Open DOISearch in Google Scholar
[7. Mysorekar VV, Dandekar CP, Prakash BS. Mast cells in Helicobacter pylori associated antral gastritis. Indian J Pathol Microbiol. 2003; 46:605-9.]Search in Google Scholar
[8. Nakajima S, Bamba N, Hattori T. Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis. Aliment Pharmacol Ther. 2004; 20 Suppl 1: 165-70.10.1111/j.1365-2036.2004.01974.x15298623]Open DOISearch in Google Scholar
[9. Kayaselcuk F, Serin E, Gumurdulu Y, Bircan S, Tuncer I. Relationship between gastritis severity, Helicobacter pylori intensity and mast cell density in the antrum and corpus. Turk J Gastroenterol. 2002; 13:154-8.]Search in Google Scholar
[10. Chen XY, Liu WZ, Shi Y, Zhang DZ, Xiao SD, Tytgat GN. Helicobacter pylori associated gastric diseases and lymphoid tissue hyperplasia in gastric antral mucosa. J Clin Pathol. 2002; 55:133-7.10.1136/jcp.55.2.133176958611865009]Open DOISearch in Google Scholar
[11. Vivatvakin B, Theamboonlers A, Semakachorn N, Wongsawadi L. Prevalence of CagA and VacA genotype of Helicobacter pylori in Thai children. J Med Assoc Thai. 2004; 87:1327-31.]Search in Google Scholar
[12. Velin D, Michetti P. Immunology of Helicobacter pylori infection. Digestion. 2006; 73:116-23.10.1159/00009404316788292]Search in Google Scholar
[13. Matsuhisa TM, Yamada NY, Kato SK, Matsukura NM. Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: a comparative study in age-, gender- and endoscopic diagnosis-matched subjects. Helicobacter. 2003; 8: 29-35.10.1046/j.1523-5378.2003.00121.x12603614]Open DOISearch in Google Scholar
[14. Matsuo T, Ikura Y, Ohsawa M, Ogami M, Kayo S, Yoshimi N, et al. Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology. 2003; 43:538-49.10.1111/j.1365-2559.2003.01731.x]Open DOISearch in Google Scholar
[15. Saperas E. The role of mast cells in gastrointestinal inflammation. Gastroenterology. 1996; 110:1656-8.10.1053/gast.1996.v110.agast961656]Open DOISearch in Google Scholar
[16. Bodger K, Bromelow K, Wyatt JI, Heatley RV. Interleukin 10 in Helicobacter pylori associated gastritis: immunohistochemical localisation and in vitro effects on cytokine secretion. J Clin Pathol. 2001; 54:285-92.10.1136/jcp.54.4.285]Open DOISearch in Google Scholar
[17. Kempuraj D, Huang M, Kandere-Grzybowska K, Basu S, Boucher W, Letourneau R, et al. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NFkappaB activation and intracellular calcium ion levels in normal human mast cells. Int Arch Allergy Immunol. 2003; 132:231-9.10.1159/000074304]Search in Google Scholar
[18. Theoharides TC, Bielory L. Mast cells and mast cell mediators as targets of dietary supplements. Ann Allergy Asthma Immunol. 2004; 93:S24-34.10.1016/S1081-1206(10)61484-6]Open DOISearch in Google Scholar
[19. Temkin V, Kantor B, Weg V, Hartman ML, Levi-Schaffer F. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol. 2002; 169:2662-9.10.4049/jimmunol.169.5.266212193739]Search in Google Scholar
[20. Sasaki Y, Yoshimoto T, Maruyama H, Tegoshi T, Ohta N, Arizono N, Nakanishi K. IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. J Exp Med. 2005; 202:607-16.10.1084/jem.20042202221286216129701]Search in Google Scholar
[21. Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, et al. Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer. World J Gastroenterol. 2006; 12:6869-73.10.3748/wjg.v12.i42.6869408744517106939]Open DOISearch in Google Scholar
[22. Liu Y, Ponsioen CI, Xiao SD, Tytgat GN, Ten Kate FJ. Geographic pathology of Helicobacter pylori gastritis. Helicobacter. 2005; 10:107-13.10.1111/j.1523-5378.2005.00304.x15810940]Open DOISearch in Google Scholar
[23. Lin HJ, Perng CL, Lo WC, Wu CW, Tseng GY, Li AF, et al. Helicobacter pylori cagA, iceA and vacA genotypes in patients with gastric cancer in Taiwan. World J Gastroenterol. 2004; 10:2493-7. 10.3748/wjg.v10.i17.2493457214815300891]Open DOISearch in Google Scholar